TARA icon

Protara Therapeutics
TARA

Overview Fund Activity

27 hedge funds and large institutions have $20.3M invested in Protara Therapeutics in 2018 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and 2 closing their positions.

Holders
27
Holders Change
+2
Holders Change %
+8%
% of All Funds
0.62%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.09%
New
4
Increased
5
Reduced
3
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
NLVP
1
New Leaf Venture Partners
New York
$2.93M
2
Vanguard Group
2
Vanguard Group
Pennsylvania
$408K
3
Renaissance Technologies
3
Renaissance Technologies
New York
$656K
4
BFM
4
Boothbay Fund Management
New York
$207K
5
VF
5
Virtu Financial
New York
$28K

Top Sellers

1
PA
1
Perceptive Advisors
New York
$469K
2
DS
2
DRW Securities
Illinois
$48K
3
Dimensional Fund Advisors
3
Dimensional Fund Advisors
Texas
$0
4
PAM
4
Panagora Asset Management
Massachusetts
$21K
5
UBS Group
5
UBS Group
Switzerland
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
Morgan Stanley
26
Morgan Stanley
New York
$1K +$1K +11 New
Dimensional Fund Advisors
27
Dimensional Fund Advisors
Texas
– -$45K -464 Closed
UBS Group
28
UBS Group
Switzerland
– -$5K -55 Closed
1
2